Predictive Markers

The predictive power of premalignant lesions of the stomach.

A Grace MRCPath, C. Gulmann MB, D.Butler MSc, M. Leader FRCPath, MD, E. Kay FRCPath, MD.

Influence of PUFA on a prospective cancer biomarker in feline adipose

KE Saker , BE Cowing, JH Herbein

Oligoclonal expansion of B cells in the livers of hepatitis C virus infection may be associated with the development of B-cell non-Hodgkin lymphomas.

J Murakami,MD,PhD, Y Shimizu,MD,PhD, Y Kashii, MD,PhD, K Ebata, MD, T Kato, MD,A Watanabe, MD, PhD

Utilising the comet assay for the detection of mouse models in a large scale genetic screen to determine genetic components of radiation sensitivity

C. A. Schindewolf , A. Hartmann, H.V. Liebscher, W. Frieauff, H. Fuchs, E. Binder, F. Ohl, D. Soewarto, M. D. Gomolka, S. Hornhardt, T. Jung, M. M. Hrabé de Angelis

DNA repair gene polymorphisms and adult acute myeloblastic leukaemia risk

CH Seedhouse, PhD, E P Das-Gupta, MD, M Lewis and N H Russell, MD.

Genomic analysis of scirrhous gastric cancer in a young adult

H Mita MD PhD, F Itoh MD PhD, M Toyota MD PhD, and K Imai MD PhD

Molecular and histopathologic predictors of distant failures in corpus cancer

A Mariani, MD, TJ Sebo, MD, PhD, J Katzman, PhD, D Riehle, GL Keeney, MD, KC Podratz, MD, PhD

Relationship of microvessel density and VEGF with dynamic MRI parameters in breast cancer

O. Nalcioglu, Ph.D. , M-Y Su, Ph.D. , J. Fruehauf, MD/Ph.D. , Y-C. Cheung, MD , E. Mechetner, Ph.D. , A. Kyshtoobayeva, MD , S-C. Chen, MD , S. Hsueh, MD , Y-L. Wan, MD

Clinical implications of p53 tumor suppressor gene alterations in esophageal adenocarcinoma: results of a 10-year prospective study

AG Casson, FRCSC, S Evans, BSc, A Gillis, BSc, GA Porter, MD, PJ Veugelers, PhD, SJ Darnton, PhD, DL Guernsey, PhD, P Hainaut, PhD

Bcl-2, bax, and p53 immunohistochemical alternations as predictive markers for radiotherapy in patients with localized prostate cancer.

S Kariya, MD, PhD, Y Ogawa, MD, PhD, A Nishioka, MD, PhD, M Furihata, MD, PhD, K Kasahara, MD, K Inoue, MD, PhD, T Shuin, MD, PhD, S Yoshida, MD, PhD

Microvascular Changes During Inhibition of Colorectal Liver Metastases by SMANCS/Lipiodol.

D. Kuruppu PhD, H. Maeda MD, C. Christophi MD, FRACS, P. E. O'Brien MD, FRACS

Immunohistochemical expression of caveolin-1 as a marker for the biological potential of renal cell carcinoma

H Sakai, MD, K Takehara, MD, S Koga, MD, H Kanetake, MD

Cancer markers shown to be a cause as well as a consequence of cancer activity

Monique S Beljanski

Factors of cancer tolerance: increased prevalence of GSTM1 proficiency in elderly tumour-free smokers and non-smokers

E.N. Imyanitov, A.V. Togo, E.V. Belogubova, V.G. Lemehov, K.P. Hanson

Susceptibility genes for bladder cancer

S. Horn , E. Schnakenberg , R. Werdin , K. Dreikorn and W. Schloot

Potential protein markers in diagnosis and treatment of B-CLL

M. Rogalinska MSc., J. Blonski , M.D., Ph.D., M. Hanausek Ph.D., T. Robak M.D., Ph.D., Z.M. Kilianska Ph.D.

Identification and molecular characterization of NUCB2 as potential gastric cancer antigen

Zane Slucka BSc , Aija Line MSc , Aivars Stengrevics MD , Geng Li PhD , Eriks Jankevics PhD and Robert C. Rees PhD

The detection of early p53 mutations in non-dysplastic Barrett's tissues.

GJS Jenkins, SH Doak, AP Griffiths, JM Parry and JN Baxter

Characterization of an estrogen-regulated growth factor in endometrial cancer

MB Jones, MD, A Houwink, WL Lingle, PhD, EC Kohn, MD, A Berchuck, MD, KC Podratz, MD, PhD, NJ Maihle, PhD

Clinical impact of circulating tumor cells (CTC) morphological and molecular (ß catenin mutations) characterization in patients with hepatocellular carcinoma

G. Vona1, L. Estepa2, D. Damotte3, F. Capron4, C Béroud2, H Fontaine5, A. Mineur5, B. Nalpas5, H. Zylberberg5, D. Franco6, B. Lacour2, S. Pol5, C. Bréchot1,5, P. Paterlini-Bréchot

p53 gene alterations in lymph node-positive breast cancer patients on adjuvant chemotherapy

M. Brankovic-Magic , R. Jankovic , Z. Magic , B. Cikota , S. Radulovic

Sarcolectin plays a role in normal and malignant cell growth

Aboubacar Kaba Pan Hong Jiang Francoise Chany , Charles Chany

Expression of human Telomerase Reverse Transcriptase (hTERT) mRNA in tumor cells from urine, as tumor marker for monitoring both relapse and urothelial microdissemination in bladder carcinoma

N.Álvarez, F. Árias, E.Fernández, A.Escudero, MD, G. Gómez, A. Gómez, MV. Toledo, MD, A.Moyano, MD, and E. Caso, MD, PhD.

Androgen-sensitive prostate cancer is characterized by a lower malignant potential

L Bonaccorsi

The estimation of adhesion molecules sICAM-1, sICAM-2, sVCAM-1, sCD44 ST, sCD44 V5 and dendritic cells function in children with malignancies

J. Weclawek-Tompol, A. Chybicka, B. Rybka, R. Ryczan, D. Noworolska, J. Boguslawska-Jaworska

Mixed myelodysplastic and myeloproliferative syndromes (MDS-MPS), a new stem cell disorder.

R.Neuwirtová MD PhD , K.Michalová PhD , B.Novotná PhD

DNA content as a possible marker of preneoplasia in renal cysts with comparison of solid and cystic renal cancer.

J. Kovacs, E. Szabo, A. Varga , T. Nemeth, S. Gomba, J. Kappelmayer

Prognosis value of cytokine levels in response to chemotherapy in non small cell lung cancer

BA Alvarez PhD, MR Alemán Valls MD , M Llanos Muñoz MD , J Oramas Rodríguez MD , , J Cruz Jurado MD , L Rodríguez Rodríguez PhD , A Martínez Riera MD , E González Reimers MD , F Santolaria Fernández MD , Batista López MD .